Venetoclax and Obinutuzumab for Relapsed/Refractory Primary CNS Lymphoma
Clinical trial NCT04073147 · TERMINATED
Trial details
- NCT number
- NCT04073147
- Sponsor
- Klinikum Stuttgart
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-12
- Primary completion
- 2021-11-25
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.